Drug makers may spend 20% of revenue on R&D

Cleanup drive to sweep the local pharmaceutical industry will give drug makers an opportunity to invest the money saved from the elimination of illegal rebates into research and development by 20 percent, according to experts.

In its 2008 Medicine Industry Report, the Korea Health Industry Development Institute said 120 domestic drug makers dished out a total of 4.173 trillion won over a on...